Soleus Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,678
| Closed | -$276K | – | 94 |
|
|
2024
Q3 | $276K | Sell |
9,678
-242,222
| -96% | -$6.91M | 0.02% | 85 |
|
|
2024
Q2 | $6.65M | Sell |
251,900
-12,750
| -5% | -$337K | 0.59% | 55 |
|
|
2024
Q1 | $8.55M | Sell |
264,650
-52,400
| -17% | -$1.69M | 0.63% | 48 |
|
|
2023
Q4 | $13.4M | Sell |
317,050
-82,549
| -21% | -$3.48M | 1.48% | 22 |
|
|
2023
Q3 | $15.3M | Buy |
399,599
+226,000
| +130% | +$8.68M | 1.42% | 24 |
|
|
2023
Q2 | $3.29M | Buy |
+173,599
| New | +$3.29M | 0.37% | 60 |
|